Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 22;15(2):e35310.
doi: 10.7759/cureus.35310. eCollection 2023 Feb.

Iron Status in Sickle Cell Anemia: Deficiency or Overload?

Affiliations

Iron Status in Sickle Cell Anemia: Deficiency or Overload?

Varsha P Patel et al. Cureus. .

Abstract

Background Sickle cell anemia (SCA) is a hereditary disease with defective hemoglobin (Hb) synthesis causing severe hemolytic anemia, pain crisis, and target organ damage. In SCA, several factors independently or in combination lead to derangement in iron stores. Some centers incorrectly prescribe iron therapy on the presumption that SCA would be associated with iron deficiency, but it is not always the case. This study attempts to evaluate the iron status in SCA patients and records the target organ damage present. Methodology A single-center cross-sectional study of 180 patients with sickle cell disease was carried out at a tertiary-care center in Western India. Patients >12 years of age were included in the study after confirming SCA using high-performance liquid chromatography (HPLC). The iron status of each patient was identified and patients were labeled as iron sufficient based on the following values: Hb (8.1-12 gm%), serum iron (S. iron) level (50-150 μg/dl), serum ferritin (S. ferritin) (50-200 ng/ml), and total iron binding capacity (TIBC) (251-450 µg/dl). The iron status of patients with different target organ damage was also analyzed. Results Demographic data revealed that 21-30 years was the most common age group affected by SCA along with a male preponderance. The most common presenting complaint was joint pain (68.9%), the most common sign was pallor (64.4%), most patients had a history of pain crisis (95.6%), and half of the patients had organomegaly (51.1%). Most of the patients had no complications, however, for those who did, hepatopathy (28.9%) was the most common. Conclusion While the majority of patients were iron sufficient, a considerable number had either iron deficiency or iron overload states, which emphasizes the necessity of investigating the iron status before deciding the course of treatment in SCA patients. Although the majority were unaffected, screening for end-organ damage should be carried out in all SCA patients.

Keywords: hematology; hemoglobinopathy; internal medicine; iron overload; sickle cell anemia; target organ damage.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Complications due to iron overload
Figure 2
Figure 2. Iron storage status in patients

References

    1. World Health Organization. Nicosia, Cyprus: WHO Document Production Services; 2007. Management of Haemoglobin Disorders: Report of a Joint WHO-TIF Meeting, Nicosia, Cyprus, 16-18 November 2007.
    1. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. Patel AP, Naik MR, Shah NM, Sharma NP, Parmar PH. https://njcmindia.com/index.php/file/article/view/1658 Natl J Community Med. 2012;3:112–116.
    1. Lung NH. The Management of SCD 4th ed. United States: National Heart Lung and Blood Institute; 2002.
    1. Serum ferritin and sequestered stores of body iron. Rao KR, Ray VH, Patel AR. Am J Clin Pathol. 1983;80:743–745. - PubMed
    1. The diagnosis of iron deficiency anemia in sickle cell disease. Vichinsky E, Kleman K, Embury S, Lubin B. Blood. 1981;58:963–968. - PubMed

LinkOut - more resources